Radiopharmaceutical therapy provides superior survival advantage for leptomeningeal metastasis compared to external beam radiotherapy
{{output}}
Background: Leptomeningeal metastasis from a solid tumor carries a dismal prognosis with median survival of 3 to 5 months after diagnosis and treatment with external beam radiation therapy. It targets the whole-brain or the entir... ...
